Amundi Reduces Stake in UnitedHealth Group Incorporated $UNH

Key Points

• Amundi reduced its holdings in UnitedHealth Group by 23.8%, owning approximately 4.63 million shares after selling 1.44 million during the first quarter.
• UnitedHealth Group's recent earnings report showed an EPS of $4.08, missing estimates, while revenue was $111.62 billion, slightly below forecasts.
• The company declared a quarterly dividend of $2.21 per share, yielding 2.9%, with a payout ratio of 38.30%.

Amundi decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 23.8% during the first quarter, according to its most recent filing with the SEC. The firm owned 4,626,626 shares of the healthcare conglomerate's stock after selling 1,442,474 shares during the period. UnitedHealth Group comprises about 0.9% of Amundi's holdings, making the stock its 15th largest holding. Amundi owned about 0.51% of UnitedHealth Group worth $2,500,307,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in UNH. Appaloosa LP boosted its position in shares of UnitedHealth Group by 0.3% in the 1st quarter. Appaloosa LP now owns 175,000 shares of the healthcare conglomerate's stock worth $91,656,000 after purchasing an additional 500 shares in the last quarter. Aprio Wealth Management LLC boosted its position in shares of UnitedHealth Group by 10.0% in the 1st quarter. Aprio Wealth Management LLC now owns 1,471 shares of the healthcare conglomerate's stock worth $770,000 after purchasing an additional 134 shares in the last quarter. 140 Summer Partners LP bought a new stake in shares of UnitedHealth Group in the 1st quarter worth approximately $79,576,000. 683 Capital Management LLC bought a new stake in shares of UnitedHealth Group in the 1st quarter worth approximately $27,235,000. Finally, Adage Capital Partners GP L.L.C. boosted its stake in UnitedHealth Group by 0.3% during the 1st quarter. Adage Capital Partners GP L.L.C. now owns 914,051 shares of the healthcare conglomerate's stock valued at $478,734,000 after purchasing an additional 2,429 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

Wall Street Analysts Forecast Growth

Several brokerages have commented on UNH. Wolfe Research cut their target price on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating on the stock in a research note on Tuesday, May 20th. Truist Financial lowered their price target on UnitedHealth Group from $360.00 to $345.00 and set a "buy" rating on the stock in a report on Wednesday, July 16th. Piper Sandler lowered their price target on UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating on the stock in a report on Wednesday, July 30th. Barclays increased their price target on UnitedHealth Group from $337.00 to $352.00 and gave the company an "overweight" rating in a report on Thursday. Finally, Cantor Fitzgerald reissued an "overweight" rating and set a $440.00 price target on shares of UnitedHealth Group in a report on Tuesday, August 26th. Sixteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company's stock. According to data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of "Moderate Buy" and a consensus target price of $354.86.

UnitedHealth Group Stock Performance

UnitedHealth Group stock traded up $4.72 during trading on Friday, reaching $315.10. The company had a trading volume of 14,093,579 shares, compared to its average volume of 17,031,034. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The firm has a market capitalization of $285.38 billion, a price-to-earnings ratio of 13.65, a price-to-earnings-growth ratio of 2.00 and a beta of 0.45. The firm's 50-day simple moving average is $288.78 and its 200 day simple moving average is $374.41.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. During the same quarter in the previous year, the company posted $6.80 EPS. The company's quarterly revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be given a dividend of $2.21 per share. The ex-dividend date is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.8%. UnitedHealth Group's dividend payout ratio (DPR) is presently 38.30%.

Insider Buying and Selling at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 589 shares of the firm's stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the transaction, the chief executive officer owned 10,398 shares in the company, valued at $3,171,390. This trade represents a 5.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 0.28% of the stock is currently owned by insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.